尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
Overseas Regulatory Announcement
2021-04-09
Unaudited First Quarter Results of 2021
2021-04-09
Overseas Regulatory Announcement
2021-04-06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2021-04-01
Overseas Regulatory Announcement
2021-03-30
Overseas Regulatory Announcement
2021-03-30
Continuing Connected Transactions In Relation To Shandong Lukang Agreement and C
2021-03-30
Proposed Amendments of the Articles of Association
2021-03-30
Announcement for 2020 Annual Results
2021-03-30
Overseas Regulatory Announcement
2021-03-26
<
...
6
7
8
9
10
11
12
...
>